Dana-Farber Cancer Institute

Our News on Newswise
View All >

Antibody-Drug Conjugate Highly Effective in Preventing Recurrence in Patients with Early Stage HER2+ Breast Cancer, Trial Finds

• 97% of HER2+, early-stage patients treated with trastuzumab emtansine (T-DM1) were free of cancer recurrence five years after treatment • Prognostic test (HER2DX) shown helpful in identifying patients at greatest risk for recurrence
25-Jun-2024 12:05 PM EDT Add to Favorites

Newswise: 667afcbe14e73_BuildingExteriorevening.jpg

Researchers report first effective use of immunotherapy for most common subtype of colorectal cancer

These clinical trial results point to the first safe and effective use of immunotherapy for patients with microsatellite stable colorectal cancer, the most common subtype of the disease. The encouraging results of this phase I trial have prompted...
25-Jun-2024 1:05 PM EDT Add to Favorites

Newswise: 66718e78359c0_DanaFarberBuilding.jpg

Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and had longer disease-free...
18-Jun-2024 10:05 AM EDT Add to Favorites

Newswise: 6671a9dd084c2_DanielleMargalitMDMPH.jpg

New Guidelines for Radiation Therapy for HPV-Associated Head and Neck Cancer

New recommendations on the optimal use of radiation therapy for HPV-associated OPSCC are based on evidence from multiple clinical trials and aim to maintain good outcomes and reduce acute and late effects.
18-Jun-2024 11:05 AM EDT Add to Favorites

Newswise: 665dc9d6461e9_YawkeyEvening.jpg

Telehealth can significantly reduce greenhouse gas emissions associated with cancer care, study finds

Based on an analysis of data from a regional cancer center, Dana-Farber Cancer Institute researchers calculate that, nationwide, cancer care that utilizes telehealth and local care would generate 33.1% less greenhouse gas emissions than the...
3-Jun-2024 9:05 AM EDT Add to Favorites

Clinical trials show promise in treating central nervous system lymphoma, breast cancer, and glioblastoma

Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lymphoma, breast cancer, and glioblastoma. These findings are among more than 80 studies...
1-Jun-2024 8:05 AM EDT Add to Favorites

Newswise: 66570a8b10f7d_InfusionRoomNowindow.jpg

Dana-Farber researchers uncover disparities in lived experiences for patients and physicians

Four teams of Dana-Farber Cancer Institute investigators have found that people experience discrimination and bias in different ways and in more realms of cancer care than previously understood. The findings, in different studies, suggest that...
29-May-2024 8:05 AM EDT Add to Favorites

Newswise: 664f82707b43e_DanaFarberExterior.jpg

Most young women treated for breast cancer can have children, study shows

New research by Dana-Farber Cancer Institute investigators has encouraging news for young women who have survived breast cancer and want to have children.
23-May-2024 1:05 PM EDT Add to Favorites

See All News

Our Experts on Newswise

Movie release prompts national conversation about colorectal cancer in the Black community

Marvel Studios’ movie, “Black Panther: Wakanda Forever,” is the highly anticipated sequel to “Black Panther,” hitting theaters on November 11th. It will premiere without “Black Panther” star Chadwick Boseman, who passed away in 2020...
8-Nov-2022 3:05 PM EST

Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
25-Jan-2021 12:05 PM EST

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

See All Experts

Our YouTube Videos
View All >

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Experts

MEDICAL

Patrick Wen, MD

Director, Center for Neuro-Oncology

Keywords:
ASCO 2024,Brain Metastasis,Brain Tumor,Director,Lymphoma,Neuro-oncology,Professor

MEDICAL

Jennifer Yeh, PhD

Associate Scientific Researcher

Keywords:
ASCO 2024,Biology,Breast Cancer,Diabetes,Gastric Cancer,Pediatrics,Retinoblastoma

MEDICAL

Karen Wright, MD, MS

Senior Physician, Assistant Professor of Pediatrics, Harvard Medical School

Keywords:
ASCO 2024,Neuro-oncology,Pediatric Brain Tumor

MEDICAL

Riaz Gillani, MD

Physician, Instructor in Pediatrics, Harvard Medical School

Keywords:
ASCO 2024,Oncology,Pediatric,Pediatric Brain Tumor,Pediatric Hematology,pediatric solid tumors

MEDICAL

Jonathan Marron, MD, MPH

Physician, Clinical Ethicist, Boston Children's Hospital Instructor in Pediatrics, Harvard Medical School

Keywords:
ASCO 2024,Bone Cancer,clinical genomics,Kidney Cancer,Oncology,Pediatric Hematology

MEDICAL

Alanna Church, MD

Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP); Staff Pathologist Boston Children's Hospital Assistant Professor of Pathology, Harvard Medical School

Keywords:
anatomic pathology,ASCO 2024,Pathology,pediatric pathology,pediatric solid tumors,Pediatrics

MEDICAL

David Shulman, MD

Assistant Professor of Pediatrics, Harvard Medical School

Keywords:
ASCO 2024,Bone Cancer,liquid biopsies,Oncology,Pediatric Hematology,pediatric solid tumors,Sarcoma

MEDICAL

Pasi Jänne, MD, PhD

Senior Vice President for Translational Medicine Director

Keywords:
ASCO 2024,Lung Cancer,Medical Oncology,Thoracic Oncology,Translational Medicine

MEDICAL

Christopher Manz, MD, MSHP

Instructor in Medical Oncology, Harvard Medical School

Keywords:
ASCO 2024,Gastrointestinal Cancer,Instructor,Medical Oncology,Oncology

MEDICAL

Kenneth Kehl, MD, MPH

Assistant Professor of Medicine, Harvard Medical School

Keywords:
ASCO 2024,Assistant Professor,Lung Cancer,small cell,Thoracic Oncology

MEDICAL

Lakshmi Nayak, MD

Director of the Center for CNS Lymphoma

Keywords:
ASCO 2024,Ependymoma,Glioblastoma,leptomeningeal disease,Lymphoma,Meningioma,Neuro-oncology,Neurology,Paraneoplastic,Syndrome,Tumors

MEDICAL

Gilbert Youssef, MD

Instructor in Neurology, Harvard Medical School

Keywords:
ASCO 2024,Central Nervous System (CNS),Lymphoma,Neuro-oncology,Neurology

MEDICAL

Sara Tolaney, MD, MPH

Chief of the Division of Breast Oncology

Keywords:
ASCO 2024,Associate Director,breast oncology,Women's Cancers

MEDICAL

Ana Garrido-Castro, MD

Assistant Professor of Medicine at Harvard Medical School

Keywords:
ASCO 2024,Breast Cancer,breast oncology,Clinical Practice,Immunotherapy,medical oncologist

MEDICAL

Rachel Freedman, MD, MPH

Medical Oncologist, Clinical Researcher

Keywords:
ASCO 2024,Breast Cancer,breast oncology,Clinical Research,Oncologist

MEDICAL

Narjust Florez, MD

Associate Director of the Cancer Care Equity Program

Keywords:
ASCO 2024,Associate Director,Cancer Care,Cancer Health Disparities,Lung Cancer,Mesothelioma,Thoracic Oncology

MEDICAL

Toni Choueiri, MD

Director of the Lank Center for Genitourinary (GU) Oncology

Keywords:
ASCO 2024,Director,Genitourinary Cancer,Kidney Cancer,Oncology

MEDICAL

Kimia Sorouri, MD, MPH

Resident Physician

Keywords:
ASCO 2024,OBGYN,Researcher

MEDICAL

Shail Maingi, MD

Hematology/Oncology

Keywords:
ASCO 2024,Hematology,Medical Oncology

MEDICAL

Ann Partridge, MD

Medical Oncologist

Keywords:
ASCO 2024,Breast Cancer,Internal Medicine,Oncology

Contacts

Ellen Berlin Senior Director, External Communications		617-632-5357
Victoria Warren Media Relations Manager GI/GU		617-582-9323
John Noble Senior Media Relations Specialist Health Care		617-632-5784
Molly McHale Associate Director for Communications		617-632-5675
Donna Walthall Marketing Director		617-632-5856
Richard Saltus Senior Science Writer		617-632-5643
Rob Levy Science Writer		617-632-4090
Media
Cindy Cantrell Senior Media Relations Specialist
Erica Hinsley Associate Director, External Communications		508-479-3650
Nicole Oliverio Senior Media Relations Specialist		617-257-0454